|
NRD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.282000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.875000E-01 |
| Normal-vs-Stage2 |
5.687800E-01 |
| Normal-vs-Stage3 |
1.787380E-01 |
| Normal-vs-Stage4 |
1.772000E-01 |
| Stage1-vs-Stage2 |
7.433000E-01 |
| Stage1-vs-Stage3 |
1.553030E-01 |
| Stage1-vs-Stage4 |
2.734600E-01 |
| Stage2-vs-Stage3 |
5.390200E-01 |
| Stage2-vs-Stage4 |
5.733800E-01 |
| Stage3-vs-Stage4 |
9.749600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.390200E-01 |
| Normal-vs-AfricanAmerican |
3.345800E-01 |
| Normal-vs-Asian |
5.149800E-01 |
| Caucasian-vs-AfricanAmerican |
1.244440E-01 |
| Caucasian-vs-Asian |
9.837200E-01 |
| AfricanAmerican-vs-Asian |
1.556830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.570600E-01 |
| Normal-vs-Female |
4.401200E-01 |
| Male-vs-Female |
9.480400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.238400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.608950E-01 |
| Normal-vs-Age(61-80Yrs) |
5.301600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.759200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.722300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.754400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.726600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.869800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.005200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.544800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.574400E-02 |
| Classical-VS-Follicular |
4.583600E-03 |
| Classical-VS-Other |
1.853780E-01 |
| Classical-VS-Normal |
7.581200E-01 |
| Tall-VS-Follicular |
8.583000E-01 |
| Tall-VS-Other |
8.340000E-01 |
| Tall-VS-Normal |
1.200570E-01 |
| Follicular-VS-Other |
7.684000E-01 |
| Follicular-VS-Normal |
1.058220E-01 |
| Other-VS-Normal |
2.308800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.074800E-01 |
| Normal-vs-N1 |
2.755700E-02 |
| N0-vs-N1 |
2.245800E-01 |
|
|
